Key facts
- This page summarizes Jerome Riebman's Form 4 filing for AZIYO BIOLOGICS, INC. (ELUT).
- 3 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 12 Sep 2022, 17:01.
Jerome Riebman - 08 Sep 2022 Form 4 Insider Report for AZIYO BIOLOGICS, INC. (ELUT)
- Reporting relationship
- CHIEF MEDICAL OFFICER
- Issuer ticker
- ELUT
- Reported as of
- 08 Sep 2022
- Net transaction value
- -$37,259
- SEC form
- 4
- Accepted by SEC
- 12 Sep 2022, 17:01:50 UTC
- Prior SEC filing
- 10 Mar 2022
- Source filing
- View source filing
- Reporting owner signature
- /s/ Jeffrey Hamet, Attorney-in-Fact for Jerome Riebman
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Jerome Riebman filed Form 4 for AZIYO BIOLOGICS, INC. (ELUT) on 12 Sep 2022.
Change
- Previous filing in this sequence was filed on 10 Mar 2022.
- Current net transaction value: -$37,259.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
AZYO
transaction
Class A Common Stock
Options Exercise
- Transaction value
- Shares
- +14,758
- Change %
- +277%
- Price
- Shares after
- 20,093
- Date
- 08 Sep 2022
- Ownership
- Direct
- Footnotes
- F1, F2
AZYO
transaction
Class A Common Stock
Tax liability
- Transaction value
- $37,259
- Shares
- -5,104
- Change %
- -25%
- Price
- $7.30*
- Shares after
- 14,989
- Date
- 08 Sep 2022
- Ownership
- Direct
- Footnotes
- F3
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
AZYO
transaction
Derivative
Restricted Stock Units
Options Exercise
- Transaction value
- $0
- Shares
- -14,758
- Change %
- -100%
- Price
- $0.000000*
- Shares after
- 0
- Date
- 08 Sep 2022
- Ownership
- Direct
- Underlying class
- Class A Common Stock
- Underlying amount
- 14,758
- Exercise price
- Footnotes
- F1, F4
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 4 footnotes
Footnote F1
Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock. Transaction represents shares of the Issuer's Class A Common Stock received from the vesting of restricted stock units.
Footnote F2
Includes one share of the Issuer's Class A Common Stock acquired under the Issuer's 2020 Employee Stock Purchase Plan.
Footnote F3
Shares withheld by the Issuer to satisfy tax withholding requirements on vesting of restricted stock units.
Footnote F4
The restricted stock units granted on March 8, 2022 vested in full on September 8, 2022.